121.
|
Restriction Enzyme Analysis -ulse Field Gel Electrophoresis {REA-PFGE} [gen./in¿.gen.] [bioch.] [diag.] trafno¶æ: 6.7pkt.zaloguj siê |
122.
|
Neonatal jaundice from breast milk inhibitor
³ac.Icterus neonatorum propter inhibitorem in lacte matris[med.] [gastr/hepat] [ped./neonat.] trafno¶æ: 6.7pkt.zaloguj siê |
123.
|
Acquired drug-induced enzyme deficiency anaemia
³ac.Anaemia haemolytica acquisita postmedicamentosa e deficientia enzymatica[med.] [hem.] trafno¶æ: 6.7pkt.zaloguj siê |
124.
|
X chromosome-linked inhibitor of apoptosis {XIAP} [med.] [bioch.] [gen./in¿.gen.] trafno¶æ: 6.7pkt.zaloguj siê |
125.
|
cellular inhibitor of apoptosis protein 2 {c-IAP2} [bioch.] [biotech.] trafno¶æ: 6.7pkt.zaloguj siê |
126.
|
Thrombin activatable fibrinolysis inhibitor {TAFI} [hem.] trafno¶æ: 6.7pkt.zaloguj siê |
127.
|
Thrombin Activable Fibrinolysis Inhibitor {TAFI} [hem.] trafno¶æ: 6.7pkt.zaloguj siê |
128.
|
Renin–angiotensin–aldosterone system {RAA} [end.] trafno¶æ: 6.7pkt.zaloguj siê |
129.
|
Restriction Enzyme Analysis – Pulssed Field Gel Electrophoresis {REA-PFGE} [bioch.] [gen./in¿.gen.] trafno¶æ: 6.6pkt.zaloguj siê |
130.
|
Anaemia due to enzyme deficiencies, related to the hexose monophosphate (HMP) shunt pathway
³ac.Anaemia ex insufficientia cycli monophosphatis hexosi (HMP)[med.] [hem.] [bioch.] trafno¶æ: 6.6pkt.zaloguj siê |
* Dok³adamy wszelkich starañ, aby wprowadzane przez nas has³a by³y poprawne. Jednak mimo weryfikacji, mog± pojawiæ siê b³êdy, za które wydawca nie bierze odpowiedzialno¶ci. Ka¿dy u¿ytkownik wykorzystuje has³a zawarte w s³owniku Verba Medica na w³asn± odpowiedzialno¶æ.